{
	"@context": {
		"rdf": "http://www.w3.org/1999/02/22-rdf-syntax-ns#",
		"dct": "http://purl.org/dc/terms/",
		"owl": "http://www.w3.org/2002/07/owl#",
		"xsd": "http://www.w3.org/2001/XMLSchema#",
		"rdfs": "http://www.w3.org/2000/01/rdf-schema#",
		"@vocab": "http://ld.nice.org.uk/ns/bnf#",
		"bnf": "http://ld.nice.org.uk/ns/bnf/",
		"nicebnf": "http://ld.nice.org.uk/ns/bnf#",
		"route": "http://ld.nice.org.uk/ns/bnf/Route#",
		"patientGroup": "http://ld.nice.org.uk/ns/bnf/PatientGroup#",
		"indication": "http://ld.nice.org.uk/ns/bnf/Indication#",
		"sideEffect": "http://ld.nice.org.uk/ns/bnf/SideEffect#",
		"classification": "http://ld.nice.org.uk/ns/bnf/Classification#",
		"isLinkedFrom": {
			"@container": "@set"
		},
		"hasInteraction": {
			"@container": "@set"
		},
		"hasMessage": {
			"@container": "@set"
		},
		"hasInteractionList": {
			"@container": "@set"
		},
		"isInteractionListOf": {
			"@container": "@set"
		}
	},
	"@graph": [
		{
			"@id": "http://bnf.nice.org.uk/interaction/alendronic-acid-2",
			"@type": "InteractionList",
			"hasInteraction": [
				{
					"@id": "http://bnf.nice.org.uk/interaction/alendronic-acid-2#bnf_i1557280680096",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/alendronic-acid-2#bnf_i1557280680096_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"aceclofenac\" outputclass=\"int-drug\">Aceclofenac</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of gastrointestinal irritation when given with</ph> <ph otherprops=\"alendronic acid\" outputclass=\"int-heading-drug\">alendronic acid</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Aceclofenac   is predicted to   increase   the risk of gastrointestinal irritation when given with   alendronic acid .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "1",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Aceclofenac</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/alendronic-acid-2#bnf_i1557280680097",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/alendronic-acid-2#bnf_i1557280680097_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"aluminium hydroxide\" outputclass=\"int-drug\">Aluminium hydroxide</ph> <ph outputclass=\"int-effect\">decreases</ph> <ph outputclass=\"int-parameter\">the absorption of</ph> <ph otherprops=\"alendronic acid\" outputclass=\"int-heading-drug\">alendronic acid</ph>. <ph outputclass=\"int-action\">Manufacturer advises <ph otherprops=\"alendronic acid\" outputclass=\"int-heading-drug\"><xref format=\"dita\" href=\"drug/alendronic-acid.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP4656\">alendronic acid</xref></ph> should be taken at least 30 minutes before <ph otherprops=\"aluminium hydroxide\" outputclass=\"int-drug\"><xref format=\"dita\" href=\"drug/aluminium-hydroxide.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP287\">aluminium hydroxide</xref></ph></ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Aluminium hydroxide   decreases   the absorption of   alendronic acid .  Manufacturer advises  alendronic acid  should be taken at least 30 minutes before  aluminium hydroxide .    \n\n"
						}
					],
					"hasOrder": "2",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Aluminium hydroxide</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/alendronic-acid-2#bnf_i1557280680098",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/alendronic-acid-2#bnf_i1557280680098_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"amikacin\" outputclass=\"int-drug\">Amikacin</ph> <ph outputclass=\"int-effect\">increases</ph> <ph outputclass=\"int-parameter\">the risk of hypocalcaemia when given with</ph> <ph otherprops=\"alendronic acid\" outputclass=\"int-heading-drug\">alendronic acid</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Anecdotal",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Amikacin   increases   the risk of hypocalcaemia when given with   alendronic acid .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "3",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Amikacin</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/alendronic-acid-2#bnf_i1557280680099",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/alendronic-acid-2#bnf_i1557280680099_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"aspirin\" outputclass=\"int-drug\">Aspirin</ph> <ph outputclass=\"int-substanceQualifier\">(high-dose)</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of gastrointestinal irritation when given with</ph> <ph otherprops=\"alendronic acid\" outputclass=\"int-heading-drug\">alendronic acid</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Aspirin   (high-dose)   is predicted to   increase   the risk of gastrointestinal irritation when given with   alendronic acid .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "4",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Aspirin</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/alendronic-acid-2#bnf_i1557280680100",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/alendronic-acid-2#bnf_i1557280680100_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"benzydamine\" outputclass=\"int-drug\">Benzydamine</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of gastrointestinal irritation when given with</ph> <ph otherprops=\"alendronic acid\" outputclass=\"int-heading-drug\">alendronic acid</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Benzydamine   is predicted to   increase   the risk of gastrointestinal irritation when given with   alendronic acid .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "5",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Benzydamine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/alendronic-acid-2#bnf_i1557280680101",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/alendronic-acid-2#bnf_i1557280680101_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"bromfenac\" outputclass=\"int-drug\">Bromfenac</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of gastrointestinal irritation when given with</ph> <ph otherprops=\"alendronic acid\" outputclass=\"int-heading-drug\">alendronic acid</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Bromfenac   is predicted to   increase   the risk of gastrointestinal irritation when given with   alendronic acid .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "6",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Bromfenac</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/alendronic-acid-2#bnf_i1557280680102",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/alendronic-acid-2#bnf_i1557280680102_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Oral</ph> <ph otherprops=\"calcium acetate\" outputclass=\"int-drug\">calcium acetate</ph> <ph outputclass=\"int-effect\">decreases</ph> <ph outputclass=\"int-parameter\">the absorption of</ph> <ph otherprops=\"alendronic acid\" outputclass=\"int-heading-drug\">alendronic acid</ph>. <ph outputclass=\"int-action\">Manufacturer advises <ph otherprops=\"alendronic acid\" outputclass=\"int-heading-drug\"><xref format=\"dita\" href=\"drug/alendronic-acid.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP4656\">alendronic acid</xref></ph> should be taken at least 30 minutes before <ph otherprops=\"calcium acetate\" outputclass=\"int-drug\"><xref format=\"dita\" href=\"drug/calcium-acetate.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP104228\">calcium acetate</xref></ph></ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Oral   calcium acetate   decreases   the absorption of   alendronic acid .  Manufacturer advises  alendronic acid  should be taken at least 30 minutes before  calcium acetate .    \n\n"
						}
					],
					"hasOrder": "7",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Calcium acetate</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/alendronic-acid-2#bnf_i1557280680103",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/alendronic-acid-2#bnf_i1557280680103_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Oral</ph> <ph otherprops=\"calcium carbonate\" outputclass=\"int-drug\">calcium carbonate</ph> <ph outputclass=\"int-effect\">decreases</ph> <ph outputclass=\"int-parameter\">the absorption of</ph> <ph otherprops=\"alendronic acid\" outputclass=\"int-heading-drug\">alendronic acid</ph>. <ph outputclass=\"int-action\">Manufacturer advises <ph otherprops=\"alendronic acid\" outputclass=\"int-heading-drug\"><xref format=\"dita\" href=\"drug/alendronic-acid.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP4656\">alendronic acid</xref></ph> should be taken at least 30 minutes before <ph otherprops=\"calcium carbonate\" outputclass=\"int-drug\"><xref format=\"dita\" href=\"drug/calcium-carbonate.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP93602\">calcium carbonate</xref></ph></ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Oral   calcium carbonate   decreases   the absorption of   alendronic acid .  Manufacturer advises  alendronic acid  should be taken at least 30 minutes before  calcium carbonate .    \n\n"
						}
					],
					"hasOrder": "8",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Calcium carbonate</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/alendronic-acid-2#bnf_i1557280680104",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/alendronic-acid-2#bnf_i1557280680104_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Oral</ph> <ph otherprops=\"calcium chloride\" outputclass=\"int-drug\">calcium chloride</ph> <ph outputclass=\"int-effect\">decreases</ph> <ph outputclass=\"int-parameter\">the absorption of</ph> <ph otherprops=\"alendronic acid\" outputclass=\"int-heading-drug\">alendronic acid</ph>. <ph outputclass=\"int-action\">Manufacturer advises <ph otherprops=\"alendronic acid\" outputclass=\"int-heading-drug\"><xref format=\"dita\" href=\"drug/alendronic-acid.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP4656\">alendronic acid</xref></ph> should be taken at least 30 minutes before <ph otherprops=\"calcium chloride\" outputclass=\"int-drug\"><xref format=\"dita\" href=\"drug/calcium-chloride.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP93603\">calcium chloride</xref></ph></ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Oral   calcium chloride   decreases   the absorption of   alendronic acid .  Manufacturer advises  alendronic acid  should be taken at least 30 minutes before  calcium chloride .    \n\n"
						}
					],
					"hasOrder": "9",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Calcium chloride</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/alendronic-acid-2#bnf_i1557280680105",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/alendronic-acid-2#bnf_i1557280680105_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Oral</ph> <ph otherprops=\"calcium gluconate\" outputclass=\"int-drug\">calcium gluconate</ph> <ph outputclass=\"int-effect\">decreases</ph> <ph outputclass=\"int-parameter\">the absorption of</ph> <ph otherprops=\"alendronic acid\" outputclass=\"int-heading-drug\">alendronic acid</ph>. <ph outputclass=\"int-action\">Manufacturer advises <ph otherprops=\"alendronic acid\" outputclass=\"int-heading-drug\"><xref format=\"dita\" href=\"drug/alendronic-acid.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP4656\">alendronic acid</xref></ph> should be taken at least 30 minutes before <ph otherprops=\"calcium gluconate\" outputclass=\"int-drug\"><xref format=\"dita\" href=\"drug/calcium-gluconate.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP93600\">calcium gluconate</xref></ph></ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Oral   calcium gluconate   decreases   the absorption of   alendronic acid .  Manufacturer advises  alendronic acid  should be taken at least 30 minutes before  calcium gluconate .    \n\n"
						}
					],
					"hasOrder": "10",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Calcium gluconate</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/alendronic-acid-2#bnf_i1557280680106",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/alendronic-acid-2#bnf_i1557280680106_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Oral</ph> <ph otherprops=\"calcium lactate\" outputclass=\"int-drug\">calcium lactate</ph> <ph outputclass=\"int-effect\">decreases</ph> <ph outputclass=\"int-parameter\">the absorption of</ph> <ph otherprops=\"alendronic acid\" outputclass=\"int-heading-drug\">alendronic acid</ph>. <ph outputclass=\"int-action\">Manufacturer advises <ph otherprops=\"alendronic acid\" outputclass=\"int-heading-drug\"><xref format=\"dita\" href=\"drug/alendronic-acid.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP4656\">alendronic acid</xref></ph> should be taken at least 30 minutes before <ph otherprops=\"calcium lactate\" outputclass=\"int-drug\"><xref format=\"dita\" href=\"drug/calcium-lactate.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP93601\">calcium lactate</xref></ph></ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Oral   calcium lactate   decreases   the absorption of   alendronic acid .  Manufacturer advises  alendronic acid  should be taken at least 30 minutes before  calcium lactate .    \n\n"
						}
					],
					"hasOrder": "11",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Calcium lactate</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/alendronic-acid-2#bnf_i1557280680107",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/alendronic-acid-2#bnf_i1557280680107_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Oral</ph> <ph otherprops=\"calcium phosphate\" outputclass=\"int-drug\">calcium phosphate</ph> <ph outputclass=\"int-effect\">decreases</ph> <ph outputclass=\"int-parameter\">the absorption of</ph> <ph otherprops=\"alendronic acid\" outputclass=\"int-heading-drug\">alendronic acid</ph>. <ph outputclass=\"int-action\">Manufacturer advises <ph otherprops=\"alendronic acid\" outputclass=\"int-heading-drug\"><xref format=\"dita\" href=\"drug/alendronic-acid.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP4656\">alendronic acid</xref></ph> should be taken at least 30 minutes before <ph otherprops=\"calcium phosphate\" outputclass=\"int-drug\"><xref format=\"dita\" href=\"drug/calcium-phosphate.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP107980\">calcium phosphate</xref></ph></ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Oral   calcium phosphate   decreases   the absorption of   alendronic acid .  Manufacturer advises  alendronic acid  should be taken at least 30 minutes before  calcium phosphate .    \n\n"
						}
					],
					"hasOrder": "12",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Calcium phosphate</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/alendronic-acid-2#bnf_i1557280680108",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/alendronic-acid-2#bnf_i1557280680108_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"celecoxib\" outputclass=\"int-drug\">Celecoxib</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of gastrointestinal irritation when given with</ph> <ph otherprops=\"alendronic acid\" outputclass=\"int-heading-drug\">alendronic acid</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Celecoxib   is predicted to   increase   the risk of gastrointestinal irritation when given with   alendronic acid .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "13",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Celecoxib</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/alendronic-acid-2#bnf_i1557280680109",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/alendronic-acid-2#bnf_i1557280680109_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"alendronic acid\" outputclass=\"int-heading-drug\">Alendronic acid</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of gastrointestinal bleeding when given with</ph> <ph otherprops=\"deferasirox\" outputclass=\"int-drug\">deferasirox</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Alendronic acid   is predicted to   increase   the risk of gastrointestinal bleeding when given with   deferasirox .  Manufacturer advises caution .    \n\n"
						}
					],
					"hasOrder": "14",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Deferasirox</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/alendronic-acid-2#bnf_i1557280680110",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/alendronic-acid-2#bnf_i1557280680110_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"dexibuprofen\" outputclass=\"int-drug\">Dexibuprofen</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of gastrointestinal irritation when given with</ph> <ph otherprops=\"alendronic acid\" outputclass=\"int-heading-drug\">alendronic acid</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Dexibuprofen   is predicted to   increase   the risk of gastrointestinal irritation when given with   alendronic acid .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "15",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Dexibuprofen</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/alendronic-acid-2#bnf_i1557280680111",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/alendronic-acid-2#bnf_i1557280680111_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"dexketoprofen\" outputclass=\"int-drug\">Dexketoprofen</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of gastrointestinal irritation when given with</ph> <ph otherprops=\"alendronic acid\" outputclass=\"int-heading-drug\">alendronic acid</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Dexketoprofen   is predicted to   increase   the risk of gastrointestinal irritation when given with   alendronic acid .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "16",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Dexketoprofen</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/alendronic-acid-2#bnf_i1557280680112",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/alendronic-acid-2#bnf_i1557280680112_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"diclofenac\" outputclass=\"int-drug\">Diclofenac</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of gastrointestinal irritation when given with</ph> <ph otherprops=\"alendronic acid\" outputclass=\"int-heading-drug\">alendronic acid</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Diclofenac   is predicted to   increase   the risk of gastrointestinal irritation when given with   alendronic acid .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "17",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Diclofenac</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/alendronic-acid-2#bnf_i1557280680113",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/alendronic-acid-2#bnf_i1557280680113_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"etodolac\" outputclass=\"int-drug\">Etodolac</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of gastrointestinal irritation when given with</ph> <ph otherprops=\"alendronic acid\" outputclass=\"int-heading-drug\">alendronic acid</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Etodolac   is predicted to   increase   the risk of gastrointestinal irritation when given with   alendronic acid .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "18",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Etodolac</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/alendronic-acid-2#bnf_i1557280680114",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/alendronic-acid-2#bnf_i1557280680114_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"etoricoxib\" outputclass=\"int-drug\">Etoricoxib</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of gastrointestinal irritation when given with</ph> <ph otherprops=\"alendronic acid\" outputclass=\"int-heading-drug\">alendronic acid</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Etoricoxib   is predicted to   increase   the risk of gastrointestinal irritation when given with   alendronic acid .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "19",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Etoricoxib</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/alendronic-acid-2#bnf_i1557280680115",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/alendronic-acid-2#bnf_i1557280680115_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"felbinac\" outputclass=\"int-drug\">Felbinac</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of gastrointestinal irritation when given with</ph> <ph otherprops=\"alendronic acid\" outputclass=\"int-heading-drug\">alendronic acid</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Felbinac   is predicted to   increase   the risk of gastrointestinal irritation when given with   alendronic acid .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "20",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Felbinac</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/alendronic-acid-2#bnf_i1557280680116",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/alendronic-acid-2#bnf_i1557280680116_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"flurbiprofen\" outputclass=\"int-drug\">Flurbiprofen</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of gastrointestinal irritation when given with</ph> <ph otherprops=\"alendronic acid\" outputclass=\"int-heading-drug\">alendronic acid</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Flurbiprofen   is predicted to   increase   the risk of gastrointestinal irritation when given with   alendronic acid .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "21",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Flurbiprofen</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/alendronic-acid-2#bnf_i1557280680117",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/alendronic-acid-2#bnf_i1557280680117_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"gentamicin\" outputclass=\"int-drug\">Gentamicin</ph> <ph outputclass=\"int-effect\">increases</ph> <ph outputclass=\"int-parameter\">the risk of hypocalcaemia when given with</ph> <ph otherprops=\"alendronic acid\" outputclass=\"int-heading-drug\">alendronic acid</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Anecdotal",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Gentamicin   increases   the risk of hypocalcaemia when given with   alendronic acid .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "22",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Gentamicin</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/alendronic-acid-2#bnf_i1557280680118",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/alendronic-acid-2#bnf_i1557280680118_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"ibuprofen\" outputclass=\"int-drug\">Ibuprofen</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of gastrointestinal irritation when given with</ph> <ph otherprops=\"alendronic acid\" outputclass=\"int-heading-drug\">alendronic acid</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Ibuprofen   is predicted to   increase   the risk of gastrointestinal irritation when given with   alendronic acid .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "23",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Ibuprofen</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/alendronic-acid-2#bnf_i1557280680119",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/alendronic-acid-2#bnf_i1557280680119_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"indometacin\" outputclass=\"int-drug\">Indometacin</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of gastrointestinal irritation when given with</ph> <ph otherprops=\"alendronic acid\" outputclass=\"int-heading-drug\">alendronic acid</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Indometacin   is predicted to   increase   the risk of gastrointestinal irritation when given with   alendronic acid .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "24",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Indometacin</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/alendronic-acid-2#bnf_i1557280680120",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/alendronic-acid-2#bnf_i1557280680120_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"ketoprofen\" outputclass=\"int-drug\">Ketoprofen</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of gastrointestinal irritation when given with</ph> <ph otherprops=\"alendronic acid\" outputclass=\"int-heading-drug\">alendronic acid</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Ketoprofen   is predicted to   increase   the risk of gastrointestinal irritation when given with   alendronic acid .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "25",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Ketoprofen</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/alendronic-acid-2#bnf_i1557280680121",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/alendronic-acid-2#bnf_i1557280680121_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"ketorolac\" outputclass=\"int-drug\">Ketorolac</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of gastrointestinal irritation when given with</ph> <ph otherprops=\"alendronic acid\" outputclass=\"int-heading-drug\">alendronic acid</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Ketorolac   is predicted to   increase   the risk of gastrointestinal irritation when given with   alendronic acid .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "26",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Ketorolac</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/alendronic-acid-2#bnf_i1557280680122",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/alendronic-acid-2#bnf_i1557280680122_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Oral</ph> <ph otherprops=\"magnesium\" outputclass=\"int-drug\">magnesium</ph> <ph outputclass=\"int-effect\">decreases</ph> <ph outputclass=\"int-parameter\">the absorption of</ph> <ph otherprops=\"alendronic acid\" outputclass=\"int-heading-drug\">alendronic acid</ph>. <ph outputclass=\"int-action\">Manufacturer advises <ph otherprops=\"alendronic acid\" outputclass=\"int-heading-drug\"><xref format=\"dita\" href=\"drug/alendronic-acid.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP4656\">alendronic acid</xref></ph> should be taken at least 30 minutes before <ph otherprops=\"magnesium\" outputclass=\"int-drug\">magnesium</ph> (<ph otherprops=\"magnesium aspartate\" outputclass=\"int-drug\"><xref format=\"dita\" href=\"drug/magnesium-aspartate.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP14090\">magnesium aspartate</xref></ph>, <ph otherprops=\"magnesium glycerophosphate\" outputclass=\"int-drug\"><xref format=\"dita\" href=\"drug/magnesium-glycerophosphate.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP14092\">magnesium glycerophosphate</xref></ph>, <ph otherprops=\"magnesium hydroxide\" outputclass=\"int-drug\"><xref format=\"dita\" href=\"drug/magnesium-hydroxide.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP104230\">magnesium hydroxide</xref></ph>, <ph otherprops=\"magnesium sulfate\" outputclass=\"int-drug\"><xref format=\"dita\" href=\"drug/magnesium-sulfate.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP6120\">magnesium sulfate</xref></ph>)</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Oral   magnesium   decreases   the absorption of   alendronic acid .  Manufacturer advises  alendronic acid  should be taken at least 30 minutes before  magnesium  ( magnesium aspartate ,  magnesium glycerophosphate ,  magnesium hydroxide ,  magnesium sulfate ) .    \n\n"
						}
					],
					"hasOrder": "27",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Magnesium</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/alendronic-acid-2#bnf_i1557280680123",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/alendronic-acid-2#bnf_i1557280680123_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"magnesium carbonate\" outputclass=\"int-drug\">Magnesium carbonate</ph> <ph outputclass=\"int-effect\">decreases</ph> <ph outputclass=\"int-parameter\">the absorption of</ph> <ph otherprops=\"alendronic acid\" outputclass=\"int-heading-drug\">alendronic acid</ph>. <ph outputclass=\"int-action\">Manufacturer advises <ph otherprops=\"alendronic acid\" outputclass=\"int-heading-drug\"><xref format=\"dita\" href=\"drug/alendronic-acid.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP4656\">alendronic acid</xref></ph> should be taken at least 30 minutes before <ph otherprops=\"magnesium carbonate\" outputclass=\"int-drug\"><xref format=\"dita\" href=\"drug/magnesium-carbonate.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP298\">magnesium carbonate</xref></ph></ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Magnesium carbonate   decreases   the absorption of   alendronic acid .  Manufacturer advises  alendronic acid  should be taken at least 30 minutes before  magnesium carbonate .    \n\n"
						}
					],
					"hasOrder": "28",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Magnesium carbonate</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/alendronic-acid-2#bnf_i1557280680124",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/alendronic-acid-2#bnf_i1557280680124_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"magnesium trisilicate\" outputclass=\"int-drug\">Magnesium trisilicate</ph> <ph outputclass=\"int-effect\">decreases</ph> <ph outputclass=\"int-parameter\">the absorption of</ph> <ph otherprops=\"alendronic acid\" outputclass=\"int-heading-drug\">alendronic acid</ph>. <ph outputclass=\"int-action\">Manufacturer advises <ph otherprops=\"alendronic acid\" outputclass=\"int-heading-drug\"><xref format=\"dita\" href=\"drug/alendronic-acid.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP4656\">alendronic acid</xref></ph> should be taken at least 30 minutes before <ph otherprops=\"magnesium trisilicate\" outputclass=\"int-drug\"><xref format=\"dita\" href=\"drug/magnesium-trisilicate.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP304\">magnesium trisilicate</xref></ph></ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Magnesium trisilicate   decreases   the absorption of   alendronic acid .  Manufacturer advises  alendronic acid  should be taken at least 30 minutes before  magnesium trisilicate .    \n\n"
						}
					],
					"hasOrder": "29",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Magnesium trisilicate</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/alendronic-acid-2#bnf_i1557280680125",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/alendronic-acid-2#bnf_i1557280680125_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"mefenamic acid\" outputclass=\"int-drug\">Mefenamic acid</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of gastrointestinal irritation when given with</ph> <ph otherprops=\"alendronic acid\" outputclass=\"int-heading-drug\">alendronic acid</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Mefenamic acid   is predicted to   increase   the risk of gastrointestinal irritation when given with   alendronic acid .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "30",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Mefenamic acid</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/alendronic-acid-2#bnf_i1557280680126",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/alendronic-acid-2#bnf_i1557280680126_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"meloxicam\" outputclass=\"int-drug\">Meloxicam</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of gastrointestinal irritation when given with</ph> <ph otherprops=\"alendronic acid\" outputclass=\"int-heading-drug\">alendronic acid</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Meloxicam   is predicted to   increase   the risk of gastrointestinal irritation when given with   alendronic acid .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "31",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Meloxicam</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/alendronic-acid-2#bnf_i1557280680127",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/alendronic-acid-2#bnf_i1557280680127_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"nabumetone\" outputclass=\"int-drug\">Nabumetone</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of gastrointestinal irritation when given with</ph> <ph otherprops=\"alendronic acid\" outputclass=\"int-heading-drug\">alendronic acid</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Nabumetone   is predicted to   increase   the risk of gastrointestinal irritation when given with   alendronic acid .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "32",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Nabumetone</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/alendronic-acid-2#bnf_i1557280680128",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/alendronic-acid-2#bnf_i1557280680128_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"naproxen\" outputclass=\"int-drug\">Naproxen</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of gastrointestinal irritation when given with</ph> <ph otherprops=\"alendronic acid\" outputclass=\"int-heading-drug\">alendronic acid</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Naproxen   is predicted to   increase   the risk of gastrointestinal irritation when given with   alendronic acid .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "33",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Naproxen</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/alendronic-acid-2#bnf_i1557280680129",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/alendronic-acid-2#bnf_i1557280680129_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"nepafenac\" outputclass=\"int-drug\">Nepafenac</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of gastrointestinal irritation when given with</ph> <ph otherprops=\"alendronic acid\" outputclass=\"int-heading-drug\">alendronic acid</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Nepafenac   is predicted to   increase   the risk of gastrointestinal irritation when given with   alendronic acid .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "34",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Nepafenac</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/alendronic-acid-2#bnf_i1557280680130",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/alendronic-acid-2#bnf_i1557280680130_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"alendronic acid\" outputclass=\"int-heading-drug\">Alendronic acid</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the effects of</ph> <ph otherprops=\"parathyroid hormone\" outputclass=\"int-drug\">parathyroid hormone</ph>. <ph outputclass=\"int-action\">Manufacturer advises avoid</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Alendronic acid   is predicted to   decrease   the effects of   parathyroid hormone .  Manufacturer advises avoid .    \n\n"
						}
					],
					"hasOrder": "35",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Parathyroid hormone</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/alendronic-acid-2#bnf_i1557280680131",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/alendronic-acid-2#bnf_i1557280680131_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"parecoxib\" outputclass=\"int-drug\">Parecoxib</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of gastrointestinal irritation when given with</ph> <ph otherprops=\"alendronic acid\" outputclass=\"int-heading-drug\">alendronic acid</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Parecoxib   is predicted to   increase   the risk of gastrointestinal irritation when given with   alendronic acid .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "36",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Parecoxib</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/alendronic-acid-2#bnf_i1557280680132",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/alendronic-acid-2#bnf_i1557280680132_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"piroxicam\" outputclass=\"int-drug\">Piroxicam</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of gastrointestinal irritation when given with</ph> <ph otherprops=\"alendronic acid\" outputclass=\"int-heading-drug\">alendronic acid</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Piroxicam   is predicted to   increase   the risk of gastrointestinal irritation when given with   alendronic acid .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "37",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Piroxicam</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/alendronic-acid-2#bnf_i1557280680133",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/alendronic-acid-2#bnf_i1557280680133_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"streptomycin\" outputclass=\"int-drug\">Streptomycin</ph> <ph outputclass=\"int-effect\">increases</ph> <ph outputclass=\"int-parameter\">the risk of hypocalcaemia when given with</ph> <ph otherprops=\"alendronic acid\" outputclass=\"int-heading-drug\">alendronic acid</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Anecdotal",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Streptomycin   increases   the risk of hypocalcaemia when given with   alendronic acid .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "38",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Streptomycin</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/alendronic-acid-2#bnf_i1557280680134",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/alendronic-acid-2#bnf_i1557280680134_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"sulindac\" outputclass=\"int-drug\">Sulindac</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of gastrointestinal irritation when given with</ph> <ph otherprops=\"alendronic acid\" outputclass=\"int-heading-drug\">alendronic acid</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Sulindac   is predicted to   increase   the risk of gastrointestinal irritation when given with   alendronic acid .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "39",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Sulindac</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/alendronic-acid-2#bnf_i1557280680135",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/alendronic-acid-2#bnf_i1557280680135_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"tenoxicam\" outputclass=\"int-drug\">Tenoxicam</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of gastrointestinal irritation when given with</ph> <ph otherprops=\"alendronic acid\" outputclass=\"int-heading-drug\">alendronic acid</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Tenoxicam   is predicted to   increase   the risk of gastrointestinal irritation when given with   alendronic acid .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "40",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Tenoxicam</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/alendronic-acid-2#bnf_i1557280680136",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/alendronic-acid-2#bnf_i1557280680136_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"tiaprofenic acid\" outputclass=\"int-drug\">Tiaprofenic acid</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of gastrointestinal irritation when given with</ph> <ph otherprops=\"alendronic acid\" outputclass=\"int-heading-drug\">alendronic acid</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Tiaprofenic acid   is predicted to   increase   the risk of gastrointestinal irritation when given with   alendronic acid .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "41",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Tiaprofenic acid</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/alendronic-acid-2#bnf_i1557280680137",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/alendronic-acid-2#bnf_i1557280680137_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"tobramycin\" outputclass=\"int-drug\">Tobramycin</ph> <ph outputclass=\"int-effect\">increases</ph> <ph outputclass=\"int-parameter\">the risk of hypocalcaemia when given with</ph> <ph otherprops=\"alendronic acid\" outputclass=\"int-heading-drug\">alendronic acid</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Anecdotal",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Tobramycin   increases   the risk of hypocalcaemia when given with   alendronic acid .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "42",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Tobramycin</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/alendronic-acid-2#bnf_i1557280680138",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/alendronic-acid-2#bnf_i1557280680138_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"tolfenamic acid\" outputclass=\"int-drug\">Tolfenamic acid</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of gastrointestinal irritation when given with</ph> <ph otherprops=\"alendronic acid\" outputclass=\"int-heading-drug\">alendronic acid</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Tolfenamic acid   is predicted to   increase   the risk of gastrointestinal irritation when given with   alendronic acid .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "43",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Tolfenamic acid</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/alendronic-acid-2#bnf_i1557280680139",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/alendronic-acid-2#bnf_i1557280680139_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Oral</ph> <ph otherprops=\"zinc\" outputclass=\"int-drug\">zinc</ph> <ph outputclass=\"int-effect\">decreases</ph> <ph outputclass=\"int-parameter\">the absorption of</ph> <ph outputclass=\"int-route\">oral</ph> <ph otherprops=\"alendronic acid\" outputclass=\"int-heading-drug\">alendronic acid</ph>. <ph outputclass=\"int-action\">Manufacturer advises <ph otherprops=\"zinc\" outputclass=\"int-drug\">zinc</ph> (<ph otherprops=\"zinc acetate\" outputclass=\"int-drug\"><xref format=\"dita\" href=\"drug/zinc-acetate.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP6306\">zinc acetate</xref></ph>, <ph otherprops=\"zinc sulfate\" outputclass=\"int-drug\"><xref format=\"dita\" href=\"drug/zinc-sulfate.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP6172\">zinc sulfate</xref></ph>) should be taken at least 30 minutes before <ph otherprops=\"alendronic acid\" outputclass=\"int-heading-drug\"><xref format=\"dita\" href=\"drug/alendronic-acid.xml\" type=\"interaction\" rel=\"drug\" bnfid=\"PHP4656\">alendronic acid</xref></ph></ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Oral   zinc   decreases   the absorption of   oral   alendronic acid .  Manufacturer advises  zinc  ( zinc acetate ,  zinc sulfate ) should be taken at least 30 minutes before  alendronic acid .    \n\n"
						}
					],
					"hasOrder": "44",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Zinc</title>"
					}
				}
			],
			"hasSearchLabel": " Alendronic acid  | Interactions",
			"hasSearchLink": {
				"@id": "http://bnf.nice.org.uk/interaction/alendronic-acid-2.html"
			},
			"hasTitle": {
				"@type": "rdf:XMLLiteral",
				"@value": "<title> Alendronic acid </title>"
			},
			"rdfs:label": "alendronic acid"
		}
	]
}